Healthcare  Name:  Sector:  Chief Executive: Inotek Healthcare Andrew Salzman  Summary: Inotek discovers and develops drugs targeting cell death and inflammation with potential applications in critical care, surgery, stroke and auto-immune diseases.  Stage of Initial  Investment: Seed/Early  Liquidity: Private 100 Cummings Center 4th Floor Beverly, MA 01915 Phone: 978.232.9660 Fax: 978.232.8975
	Copyright ©2007 Rho Capital Partners, Inc.